Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |